Decay characteristics of HIV-1-infected compartments during combination therapy
暂无分享,去创建一个
Alan S. Perelson | A. Perelson | D. Ho | A. Hurley | M. Markowitz | M. Vesanen | K. Saksela | P. Essunger | Yun-zhen Cao | David D. Ho | Martin Markowitz | Arlene Hurley | Paulina Essunger | Yunzhen Cao | Mika Vesanen | Kalle Saksela | Paulina Essunger
[1] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[2] R. Steinman,et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1 , 1994, Cell.
[3] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[4] D. Ho,et al. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. , 1989, The New England journal of medicine.
[5] G. F. Burton,et al. Follicular dendritic cells and human immunodeficiency virus infectivity , 1995, Nature.
[6] Alan S. Perelson,et al. Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.
[7] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[8] D. Ho,et al. Increased viral burden and cytopathicity correlate temporally with CD4+ T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals , 1993, Journal of virology.
[9] M A Nowak,et al. Anti-viral drug treatment: dynamics of resistance in free virus and infected cell populations. , 1997, Journal of theoretical biology.
[10] Robert F. Siliciano,et al. In vivo fate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency , 1995, Nature Medicine.
[11] D. Ho,et al. Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease , 1996, Antimicrobial agents and chemotherapy.
[12] R Stalnikowicz-Darvasi,et al. Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. A critical analysis. , 1995, Journal of clinical gastroenterology.
[13] H. Gendelman,et al. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. , 1986, Science.
[14] D. Markovitz,et al. The role of mononuclear phagocytes in HTLV-III/LAV infection. , 1986, Science.
[15] M A Nowak,et al. Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[16] Robert Tibshirani,et al. Bootstrap Methods for Standard Errors, Confidence Intervals, and Other Measures of Statistical Accuracy , 1986 .
[17] A. McLean,et al. Lifespan of human lymphocyte subsets defined by CD45 isoforms , 1992, Nature.
[18] M. Vesanen,et al. Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons , 1996, Journal of virology.
[19] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[20] M. Hirsch,et al. Infection of monocyte/macrophages by human T lymphotropic virus type III. , 1986, The Journal of clinical investigation.
[21] S. Groth,et al. The evaluation of limiting dilution assays , 1982 .
[22] D. Dieterich,et al. Identification and quantitation of HIV‐1 in the liver of patients with AIDS , 1992, AIDS.